Search research articles
Contact Us
Filters
Showing results (1421-1430 of 1,535) with videos related to
Page
of 154
Sort By:
Cancer
|
March 27, 2019
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial
James M Cleary, Nora K Horick, Nadine Jackson McCleary, et al.
Cancer Research
|
May 14, 2009
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer
Sabine C Glöckner, Mashaal Dhir, Joo Mi Yi, et al.
Nature Communications
|
August 9, 2024
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma
Harshabad Singh, Kristen E Lowder, Kevin Kapner, et al.
Science (New York, N.Y.)
|
April 6, 2013
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Dan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, et al.
Plos One
|
August 29, 2018
ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts
Alice L Yuan, Christian B Ricks, Alexandra K Bohm, et al.
NPJ Biofilms and Microbiomes
|
April 8, 2024
Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma
Liuyang Cai, Hengyan Zhu, Qianqian Mou, et al.
Nature Cancer
|
January 2, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer
Nadeem Riaz, Tyler J Alban, Robert I Haddad, et al.
Cell
|
October 17, 2017
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz, Jonathan J Havel, Vladimir Makarov, et al.
Cancer Research
|
June 25, 2009
Evaluation of the 8q24 prostate cancer risk locus and MYC expression
Mark M Pomerantz, Christine A Beckwith, Meredith M Regan, et al.
Journal of the National Cancer Institute
|
May 31, 2023
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting
Simron Singh, Thomas A Hope, Emily B Bergsland, et al.
Page
of 154
Search research articles
Search
Showing results (1421-1430 of 1,535) with videos related to
Sort By:
Page
of 154
Cancer
|
March 27, 2019
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial
James M Cleary, Nora K Horick, Nadine Jackson McCleary, et al.
Cancer Research
|
May 14, 2009
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer
Sabine C Glöckner, Mashaal Dhir, Joo Mi Yi, et al.
Nature Communications
|
August 9, 2024
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma
Harshabad Singh, Kristen E Lowder, Kevin Kapner, et al.
Science (New York, N.Y.)
|
April 6, 2013
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Dan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, et al.
Plos One
|
August 29, 2018
ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts
Alice L Yuan, Christian B Ricks, Alexandra K Bohm, et al.
NPJ Biofilms and Microbiomes
|
April 8, 2024
Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma
Liuyang Cai, Hengyan Zhu, Qianqian Mou, et al.
Nature Cancer
|
January 2, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer
Nadeem Riaz, Tyler J Alban, Robert I Haddad, et al.
Cell
|
October 17, 2017
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz, Jonathan J Havel, Vladimir Makarov, et al.
Cancer Research
|
June 25, 2009
Evaluation of the 8q24 prostate cancer risk locus and MYC expression
Mark M Pomerantz, Christine A Beckwith, Meredith M Regan, et al.
Journal of the National Cancer Institute
|
May 31, 2023
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting
Simron Singh, Thomas A Hope, Emily B Bergsland, et al.
Page
of 154